NCT03740529 2026-01-27A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLEli Lilly and CompanyPhase 1/2 Completed803 enrolled 2 FDA
NCT03674411 2026-01-06Trial Evaluating MGTA-456 in Patients With High-Risk MalignancyMasonic Cancer Center, University of MinnesotaPhase 2 Active not recruiting22 enrolled 19 charts